|
Serna MJ, Rivera-Caravaca JM, Gonzalez-Conejero R, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Roldán V, Marín F. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. Eur J Clin Invest. 2018 Jun;48(6):e12929. doi: 10.1111/eci.12929. Epub 2018 Apr 17. PubMed PMID: 29577257.
AÑO: 2018; IF: 5.722
|
29577257
|
Rivera-Caravaca JM, Marín F, Esteve-Pastor MA, Valdés M, Vicente V, Roldán V, Lip GYH. Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality. Int J Clin Pract. 2018 Mar;72(3):e13069. doi: 10.1111/ijcp.13069. Epub 2018 Feb 12. PubMed PMID: 29436121.
AÑO: 2018; IF: 2.613
|
|
Proietti M, Hijazi Z, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Lane DA, Oldgren J, Roldan V, Yusuf S, Wallentin L; RE-LY Investigators. Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial. J Intern Med. 2018 Mar;283(3):282-292. doi: 10.1111/joim.12702. Epub 2017 Nov 7. PubMed PMID: 29044861.
AÑO: 2018; IF: 6.051
|
|
Del Monte A, Arroyo AB, Andrés-Manzano MJ, García-Barberá N, Caleprico MS, Vicente V, Roldán V, González-Conejero R, Martínez C, Andrés V. miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis. PLoS One. 2018 Jun 14;13(6):e0198932. doi: 10.1371/journal.pone.0198932. eCollection 2018. PubMed PMID: 29902229; PubMed Central PMCID: PMC6002112.
AÑO: 2018; IF: 2.776
|
|
Rivera-Caravaca JM, Roldán V, Romera M, Esteve-Pastor MA, Valdés M, Lip GYH, Vicente V, Marín F. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project. J Gen Intern Med. 2018 Jun;33(6):847-854. doi: 10.1007/s11606-017-4279-4. Epub 2018 Mar 22. PubMed PMID: 29569024; PubMed Central PMCID: PMC5975135.
AÑO: 2018; IF: 6.473
|